Outcome of azacitidine therapy in acute myeloid leukaemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature

Charles Craddock, Aimee Houlton, Lynn Quek, Paul Ferguson, Emmanouela Gbandi, Corran Roberts, Marlen Metzner, Natalia Garcia-Martin, Alison Kennedy, Angela Hamblin, Manoj Raghavan, Sandeep Nagra, Louise Hopkins, Keith Wheatley, Mary Frances McMullin, Srinivas Pillai, Richard Kelly, Shamyla Siddique, Michael Dennis, Jamie D. CavenaghParesh Vyas

Research output: Contribution to journal › Article › peer-review

39 Citations (Scopus)
177 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Outcome of azacitidine therapy in acute myeloid leukaemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature'. Together they form a unique fingerprint.

Medicine & Life Sciences